Charles Windon MD
Assistant Professor, UCSF Memory and Aging Center, UCSF Department of Neurology
Join to View Full Profile
675 Nelson Rising LaneSuite 190San Francisco, CA 94158
Phone+1 415-514-8507
Dr. Windon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Behavioral Neurology, 2019 - 2021
UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Neurology, 2016 - 2019
Rutgers Robert Wood Johnson Medical SchoolClass of 2015
Princeton UniversityBA, Molecular Biology, 2006 - 2010
Certifications & Licensure
CA State Medical License 2019 - 2026
PA State Medical License 2015 - 2016
American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- Amyloid PET in Sporadic Early- Versus Late-Onset Alzheimer's Disease: Comparison of the LEADS and ADNI Cohorts.Julien Lagarde, Piyush Maiti, Daniel R Schonhaut, Ganna Blazhenets, Jiaxiuxiu Zhang
Annals of Neurology. 2025-03-17 - F-MK-6240 tau PET in patients at-risk for chronic traumatic encephalopathy.Michael L Alosco, Jhony Mejía Pérez, Julia E Culhane, Ranjani Shankar, Christopher J Nowinski
Molecular Neurodegeneration. 2025-02-25 - Navigating barriers to dementia specialty care among vulnerable populations: Insight from a multidiscipline care navigation team.Charles C Windon, Stephanie Pun, Mitchel Erickson, Ashley J Jackson, Hannah Ruben
Journal of Alzheimer's Disease Reports. 2025-01-31
Journal Articles
- Racial and Ethnic Differences in Amyloid PET Positivity in Individuals With Mild Cognitive Impairment or DementiaA Secondary Analysis of the Imaging Dementia–Evidence ...Wilkins CH, Windon CC, Dilworth-Anderson P, et al., JAMA, 10/3/2022
- Perils of Race-Based Norms in Cognitive TestingCharles Windon, MD, JAMA Neurology
Press Mentions
Fewer Asian, Black, Hispanic Patients Eligible for Drugs That May Delay Alzheimer’s ProgressionOctober 14th, 2022
Neuroscientists to Reveal New Insights into Alzheimer’sOctober 20th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
